GlassScriptPhysician profile
Sean G Mayfield
NPI 1841480217
$4,338.87
in general payments reported to CMS, 2019-2025
37 companies · $736 in 2025
The $736 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $389 · 2021: $631 · 2022: $268 · 2023: $744 · 2024: $963 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,443.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $751.69 | 2023-2025 | |
| Biom'Up France Sas | $545.96 | 2020-2021 | |
| Axonics, INC. | $515.20 | 2020-2024 | Axonics |
| Medtronic, INC. | $311.32 | 2021-2025 | Interstim |
| Ethicon US, LLC | $247.74 | 2019-2025 | Vistaseal, Stratafix, Ethicon |
| Smith+Nephew, INC. | $151.90 | 2022-2025 | Stravix Pl, Stravix |
| Guard Medical INC. | $138.74 | 2024 | Npseal Large |
| Lsi Solutions INC | $128.99 | 2022-2025 | Ti-Knot, Running Device |
| Prescient Surgical | $124.89 | 2019 | |
| Sanara Medtech INC. | $119.42 | 2020-2023 | Celleraterx |
| Medtronic USA, INC. | $116.33 | 2019-2020 | |
| Mimedx Group, INC. | $103.16 | 2025 | |
| Biom'Up Sa | $96.82 | 2019 | |
| Baxter Healthcare | $86.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.19 | 2020-2024 | Gattex |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $64.01 | 2024-2025 | Relizorb |
| Convatec INC. | $61.78 | 2021-2023 | |
| Dilon Technologies, INC. | $60.56 | 2024 | Hemoblast Bellows |
| Tela Bio, INC. | $59.92 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Merck Sharp & Dohme LLC | $55.53 | 2023-2024 | Dificid |
| Heron Therapeutics, INC. | $46.11 | 2023-2024 | Zynrelef |
| Allergan, INC. | $45.84 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.24 | 2019 | |
| Boston Scientific Corporation | $42.74 | 2023-2024 | Captivator II |
| Pacira Pharmaceuticals Incorporated | $41.79 | 2022-2023 | Exparel |
| Shire North American Group INC | $39.10 | 2019 | |
| Trevena, INC. | $38.47 | 2022 | |
| Hologic Sales and Service, LLC | $37.89 | 2022 | |
| Becton, Dickinson and Company | $29.67 | 2023 | Phasix Mesh |
| Acera Surgical, INC. | $27.22 | 2025 | Restrata Wound Matrix |
| Coopersurgical, INC. | $25.37 | 2021-2022 | |
| Innovation Technologies INC | $22.48 | 2024 | Irrisept |
| Baudax Bio INC. | $22.28 | 2020 | |
| Avanos Medical | $18.46 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.13 | 2025 | |
| Covidien LP | $17.74 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mayfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.